Accenture and Roche Collaborate to Enhance Digital Healthcare for Cancer Patients
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Accenture plc (ACN) PT Raised to $180 at Cantor Fitzgerald Following Strong 1Q
December 22, 2017 8:03 AM ESTCantor Fitzgerald raised its price target on Accenture plc (NYSE: ACN) to $180.00 (from $151.00) while maintaining a Overweight rating following the company's 1Q. Accenture reported 1QFY18 net revenue of $9.52 bn, vs. guidance of $9.1-9.35 bn and the FactSet consensus of $9.26 bn. Adjusted EPS for 1QFY18 were... More
